Publication | Closed Access

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

ThrombopoiesisPercutaneous Coronary InterventionThrombosisIntravenous AdministrationCardiovascular DiseaseBlood PlateletPharmacologyReversible Platelet InhibitionPharmacotherapyPlatelet AntagonistMedicineAnticoagulantCardiologyAcute Myocardial Infarction